Literature DB >> 2104631

Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure.

J L Luborsky1, I Visintin, S Boyers, T Asari, B Caldwell, A DeCherney.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) was used to detect ovarian and oocyte antibodies in serum from 45 patients with premature ovarian failure (POF). Control sera were obtained from a similar group of normally cycling women without POF. A specific antibody reaction was found when POF sera were tested against human ovary (47%) or oocytes (47%). A combined total of 69% of the sera were positive for either ovary or oocytes. Fewer sera were positive for antibodies against human thyroid (18%) or human placenta (22%), and virtually no reaction with human liver (4%) was seen. LH antibodies were detected by ELISA against LH in only 3 POF sera that also contained ovarian antibodies. Therefore, gonadotropin antibodies alone do not appear to account for POF. In addition, 2 patients were treated by immunosuppression and became pregnant coincident with a decline in the serum concentration of ovarian antibodies. In summary, the results of this study are consistent with previous immunohistochemical data which indicate that ovarian and oocyte antibodies are common in patients with POF. This supports the concept that some forms of POF are associated with an autoimmune process. Furthermore, detection of ovarian and oocyte antibodies by ELISA may permit routine diagnosis of autoimmune POF and provide a basis for therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104631     DOI: 10.1210/jcem-70-1-69

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure.

Authors:  Seby L Edassery; Seerin V Shatavi; Jeremy P Kunkel; Charles Hauer; Cosima Brucker; Krishna Penumatsa; Yi Yu; James A Dias; Judith L Luborsky
Journal:  Fertil Steril       Date:  2010-06-01       Impact factor: 7.329

Review 2.  Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.

Authors:  Emanuele Pelosi; Eleanor Simonsick; Antonino Forabosco; Jose Elias Garcia-Ortiz; David Schlessinger
Journal:  Biol Reprod       Date:  2015-04-22       Impact factor: 4.285

Review 3.  Pituitary autoimmune disease: nuances in clinical presentation.

Authors:  A Glezer; M D Bronstein
Journal:  Endocrine       Date:  2012-03-17       Impact factor: 3.633

Review 4.  Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update.

Authors:  Eusebio S Pires
Journal:  J Assist Reprod Genet       Date:  2010-06-03       Impact factor: 3.412

5.  fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.

Authors:  Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  Expert Opin Med Diagn       Date:  2011-05-01

6.  Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy.

Authors:  Wenhong Ma; Zhongping Zhan; Xiaoyan Liang; Jianhui Chen; Xingfang Huang; Caiyun Liao
Journal:  J Womens Health (Larchmt)       Date:  2013-12       Impact factor: 2.681

7.  Detection of antibodies to ovarian antigens in women with premature ovarian failure.

Authors:  N J Wheatcroft; A A Toogood; T C Li; I D Cooke; A P Weetman
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

8.  Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida.

Authors:  S H Rhim; S E Millar; F Robey; A M Luo; Y H Lou; T Yule; P Allen; J Dean; K S Tung
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

9.  Antiovarian antibodies and their effect on the outcome of assisted reproduction.

Authors:  M Narayanan; P S Murthy; S A Munaf; L C Shah; M D Kini
Journal:  J Assist Reprod Genet       Date:  1995-10       Impact factor: 3.412

10.  Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.

Authors:  Yi Yu-Rice; Seby L Edassery; Nicole Urban; Ingegerd Hellstrom; Karl Erik Hellstrom; Youping Deng; Yan Li; Judith L Luborsky
Journal:  Reproduction       Date:  2016-12-13       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.